These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 3840399

  • 1. Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex.
    Watson M, Vickroy TW, Fibiger HC, Roeske WR, Yamamura HI.
    Brain Res; 1985 Nov 04; 346(2):387-91. PubMed ID: 3840399
    [Abstract] [Full Text] [Related]

  • 2. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1986 May 04; 237(2):419-27. PubMed ID: 3754581
    [Abstract] [Full Text] [Related]

  • 3. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
    Tonnaer JA, Ernste BH, Wester J, Kelder K.
    J Chem Neuroanat; 1988 May 04; 1(2):95-110. PubMed ID: 3267343
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
    Evans RA, Watson M, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1985 Dec 04; 235(3):612-8. PubMed ID: 3841156
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM, Dawson VL, Gage FH, Fisher LJ, Hunt MA, Wamsley JK.
    Brain Res; 1991 Feb 01; 540(1-2):145-52. PubMed ID: 1905173
    [Abstract] [Full Text] [Related]

  • 11. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR, Wolfe BB.
    Mol Pharmacol; 1984 Sep 01; 26(2):164-9. PubMed ID: 6548291
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB, Creese I.
    Mol Pharmacol; 1986 Aug 01; 30(2):96-103. PubMed ID: 3755499
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
    Moret C, Pastrie I, Briley M.
    Methods Find Exp Clin Pharmacol; 1988 Oct 01; 10(10):619-21. PubMed ID: 3236936
    [Abstract] [Full Text] [Related]

  • 17. Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.
    Vickroy TW, Watson M, Leventer SM, Roeske WR, Hanin I, Yamamura HI.
    J Pharmacol Exp Ther; 1985 Dec 01; 235(3):577-82. PubMed ID: 3841155
    [Abstract] [Full Text] [Related]

  • 18. Ibotenic acid lesion of nucleus basalis magnocellularis differentially affects cholinergic, glutamatergic and GABAergic markers in cortical rat brain regions.
    Rossner S, Schliebs R, Bigl V.
    Brain Res; 1994 Dec 30; 668(1-2):85-99. PubMed ID: 7704621
    [Abstract] [Full Text] [Related]

  • 19. Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert.
    Gil DW, Wolfe BB.
    J Pharmacol Exp Ther; 1986 May 30; 237(2):577-82. PubMed ID: 3009794
    [Abstract] [Full Text] [Related]

  • 20. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
    Bloom JW, Halonen M, Lawrence LJ, Rould E, Seaver NA, Yamamura HI.
    J Pharmacol Exp Ther; 1987 Jan 30; 240(1):51-8. PubMed ID: 3806397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.